The Evidence Based Rheumatology Podcast

← The Evidence Based Rheumatology Podcast22. Dez. 2025 · 13 Min.

E130: Telitacicept for SLE

E130: Telitacicept for SLE22. Dez. 202513 Min.
In Spotify hörenFunktioniert auch im Browser
5 weitere Apps

Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patients with SLE (mixed SLE and SLE-LN). Very curious to see where the FDA goes with this one.

Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2414719